MLF2 负面调节 P53 并促进结肠直肠癌发生
Debao Fang1,2, Hao Hu2, Kailiang Zhao1,2
1Department of Thoracic Surgery, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, 230001, China.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)
|July 12, 2023
概括
骨髓性白血病因子2 (MLF2) 通过抑制USP7与p53结合来负面调节p53通路,促进结直肠癌. 在结直肠癌中,MLF2升高,与预后不佳有关.
科学领域:
- 分子生物学分子生物学
- 在瘤学瘤学.
- 生物化学 生物化学
背景情况:
- p53通路对于预防癌症至关重要,其无活化在人类恶性瘤中很常见.
- 乌比基因特异蛋白酶7 (USP7) 是通过二维基因化对p53稳定性的关键调节者.
研究的目的:
- 为了确定p53通路的新型调节者.
- 研究骨髓白血病因子2 (MLF2) 在p53调节和结直肠癌中的作用.
主要方法:
- 同免疫沉试验用于研究蛋白质相互作用.
- 西部涂抹测试以评估蛋白质水平和稳定性.
- 对患者数据的分析,以将MLF2表达与结直肠癌预后相关联.
主要成果:
- 骨髓性白血病因子2 (MLF2) 被确定为p53.3的新型负调节剂.
- MLF2直接与p53和USP7相互作用,抑制USP7介导的p53二维基因化,并促进p53的不稳定.
- 在结直肠癌组织中,MLF2表达升高,并与患者预后不佳有关.
- MLF2在结直肠癌中起着致癌作用,部分是通过抑制p53.
结论:
- MLF2作为p53功能的关键抑制剂.
- MLF2-p53轴与结直肠癌的发展和进展有关.
- 在结直肠癌中,MLF2是潜在的治疗点.
相关概念视频
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Mitogens and the Cell Cycle
6.6K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K
Mismatch Repair
4.9K
Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
4.9K
Induced Pluripotent Stem Cells
4.2K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.2K
Negative Regulator Molecules
35.5K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.5K
Mutagenicity and Carcinogenicity
1.3K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.3K


